2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Insulin-like growth factor 2 and inflammatory response in Parkinson Disease: Potential predictor marker

CA. Aguilera, FG. Grünenwald, VU. Urbina, EL. Larraechea, RLV. Vidal (Santiago, Chile)
Integrated Clinical Research Intern Program: Impact Upon Recruitment of Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention.

L. Lemon, A. Faraday, J. Nevins, M. Nygard, M. Mcmahon (Cincinnati, USA)
Integrated management of persons with Parkinsonism: a new model of patient-centered healthcare at home coordinated by a Case Manager via Telenursing.

R. Cilia, C. Leuzzi, M. Catotti, J. Cordasco, C. Moreschi, R. Eleopra (Milano, Italy)
Integrating Non-Motor Symptoms and Gender Variability in Machine Learning for Early Parkinson’s Disease Detection

MZA. Ali, PSD. Dholaniya (Hyderabad, India)
Integrating Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program

D. Vaughan, M. Theilmann Jensen, O. Serrano Asensio, T. Tharmaraja, S. Jasaityte, E. Stafford, H. Houlden, A. Huey Tan, S. Lim, H. Morris, GP2. Genetics Program (London, United Kingdom)
Intelligent Assessment of Abnormal Movements in Neurological Disorders: An Update

YJ. Bao, RH. Hong, WT. Qin, Z. Wu, YP. Song, LJ. Jin (Shanghai, China)
Intensive Neurophysiological Rehabilitation System As a New Approach for Treatment of ASD Children

T. Voloshyn (lviv, Ukraine)
Inter- and intra-day variability in β-Glucocerebrosidase activity and pathway biomarkers in healthy volunteers and patients with Parkinson’s disease with a GBA1 mutation

J. Vandervalk, D. Dumas, E. Thijssen, D. Pereira, W. Grievink, Y. Yavuz, C. Pesch, D. Ysselstein, M. Hagey, J. Cedarbaum, K. Hunt, P. Kremer (Leiden, Netherlands)
Interaction of GCase and ganglioside GM1 in the aggregation of α-Synuclein

F. Fierli, G. Uras, S. Lucas-Del Pozo, S. Koletsi, V. Lentini, M. Toffoli, P. Caboni, A. Schapira (London, United Kingdom)
Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease

K. Tosefsky, Y. Wang, A. Kuan, V. Ngo, C. Agu, D. Liang, L. Liu, O. Geiger, S. Keymanesh, M. Sacheli, E. Gerson, S. Cresswell (Vancouver, Canada)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z